Space Law/Aviation/Aerospace,
Health Care, Pharmaceuticals, Biotech
Feb. 25, 2026
The final frontier of drug development: Biotechnology and pharmaceutical innovation in low earth orbit
Scientists and companies are using the microgravity of low Earth orbit to develop drugs in ways impossible on Earth, creating new opportunities and legal challenges for space-based biotechnology and its regulation.
A quiet revolution is unfolding approximately 250 miles above the Earth's surface. In the microgravity environment of low Earth orbit (LEO), pharmaceutical companies, biotech startups and government-funded researchers are conducting experiments that may fundamentally alter how we discover, develop and manufacture drugs. For practitioners at the intersection of space law, life sciences regulation and i...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In